Health outcomes among non-Caucasian living kidney donors: Knowns and unknowns

Transplant International

Volumn 26, Issue 9, 2013, Pages 853-864

  Lentine, Krista L ^a   Segev, Dorry L ^b,c  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

health status disparities; hypertension; kidney failure; living donors; mortality; race

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN L1; UNCLASSIFIED DRUG;

ABORIGINE; AFRICAN AMERICAN; ASIAN; ATTRIBUTABLE RISK; CAUCASIAN; DIABETES MELLITUS; GENETIC VARIABILITY; GENOTYPE; HEALTH CARE DISPARITY; HEALTH CARE QUALITY; HEALTH INSURANCE; HISPANIC; HUMAN; HYPERTENSION; INFORMED CONSENT; KIDNEY DONOR; KIDNEY FAILURE; LIVING DONOR; MORTALITY; PATIENT COUNSELING; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RACE; REVIEW; RISK ASSESSMENT;

HEALTH STATUS DISPARITIES; HYPERTENSION; KIDNEY FAILURE; LIVING DONORS; MORTALITY; RACE;

AFRICAN AMERICANS; APOLIPOPROTEIN A-I; DIABETES MELLITUS; DONOR SELECTION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FOLLOW-UP STUDIES; HEALTHCARE DISPARITIES; HISPANIC AMERICANS; HUMANS; HYPERTENSION; INFORMED CONSENT; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIVING DONORS; OUTCOME ASSESSMENT (HEALTH CARE); POSTOPERATIVE COMPLICATIONS; RISK; TISSUE AND ORGAN HARVESTING; UNITED STATES;

EID: 84882453139     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/tri.12088     Document Type: Review

References (63)

1. OPTN (Organ Procurement and Transplantation Network)/UNOS (United Network for Organ Sharing). National Data Reports, Living Donors, Latest Data. Available at: http://optn.transplant.hrsa.gov/latestData/rptData.asp (accessed 12 September 2012).
2. Horvat LD, Shariff SZ, Garg AX,. Global trends in the rates of living kidney donation. Kidney Int 2009; 75: 1088.
3. OPTN (Organ Procurement and Transplantation Network) and SRTR (Scientific Registry of Transplant Recipients). OPTN/SRTR 2010 Annual Data Report. Kidney Chapter/Living Donors. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, 2011. Available at http://www.srtr.org/annual-reports/2010/ (accessed 12 September 2012).
4. Segev DL, Gentry SE, Warren DS, Reeb B, Montgomery RA,. Kidney paired donation and optimizing the use of live donor organs. JAMA 2005; 293: 1883.
5. Segev DL, Kucirka LM, Gentry SE, Montgomery RA,. Utilization and outcomes of kidney paired donation in the United States. Transplantation 2008; 86: 502.
6. Gentry SE, Montgomery RA, Segev DL,. Kidney paired donation: fundamentals, limitations, and expansions. Am J Kidney Dis 2011; 57: 144.
7. Massie AB, Gentry SE, Montgomery RA, Bingaman A, Segev DL,. Center-level utilization of kidney paired donation. Am J Transplant 2013 Mar 6. doi: 10.1111/ajt.12189. [Epub ahead of print]
8. de Klerk M, Haase-Kromwijk BJ, Witvliet M, Claas FH, Weimar W,. Favourable results of the first 2 years of the Dutch paired, living donor, kidney exchange programme. Ned Tijdschr Geneeskd 2007; 151: 130.
9. Trpeski L,. Canadian Organ Replacement Register (CORR): Recent Trends in Donor Activity. CAT Clinical Donation Symposium. March 16, 2007. Available at: http://www.slideserve.com/taran/canadian-organ-replacement-register-corr (accessed 5 November 2012).
10. Clayton P,. Update from the ANZDATA Living donor Registry. Available at: http://www.nephrology.edu.au/downloads/presentations/DNT%202011/ 05%20Kate%20Wyburn%20v1.pdf (accessed 5 November 2012).
11. Davis CL, Cooper M,. The state of U.S. living kidney donors. Clin J Am Soc Nephrol 2010; 5: 1873.
12. Reese PP, Feldman HI, McBride MA, Anderson K, Asch DA, Bloom RD,. Substantial variation in the acceptance of medically complex live kidney donors across US renal transplant centers. Am J Transplant 2008; 8: 2062.
13. Taler SJ, Messersmith EE, Leichtman AB, et al,. Demographic, metabolic, and blood pressure characteristics of living kidney donors spanning five decades. Am J Transplant 2013; 13: 390.
14. Ommen ES, Winston JA, Murphy B,. Medical risks in living kidney donors: absence of proof is not proof of absence. Clin J Am Soc Nephrol 2006; 1: 885.
15. Ibrahim HN, Foley R, Tan L, et al,. Long-term consequences of kidney donation. N Engl J Med 2009; 360: 459.
16. Gibney EM, King AL, Maluf DG, Garg AX, Parikh CR,. Living kidney donors requiring transplantation: focus on African Americans. Transplantation 2007; 84: 647.
17. Nogueira JM, Weir MR, Jacobs S, et al,. A study of renal outcomes in African American living kidney donors. Transplantation 2009; 88: 1371.
18. Storsley LJ, Young A, Rush DN, et al,. Long-term medical outcomes among Aboriginal living kidney donors. Transplantation 2010; 90: 401.
19. Lentine KL, Schnitzler MA, Xiao H, et al,. Racial variation in medical outcomes among living kidney donors. N Engl J Med 2010; 363: 724.
20. Cherikh WS, Young CJ, Kramer BF, Taranto SE, Randall HB, Fan PY,. Ethnic and gender related differences in the risk of end-stage renal disease after living kidney donation. Am J Transplant 2011; 11: 1650.
21. European Parliament C. Directive 2010/45/EU of the European Parliament and of the Council of 7 July 2010 on standards of quality and safety of human organs intended for transplantation. Available at: http://eur-lex.europa.eu/ LexUriServ/LexUriServ.do?uri=CELEX:32010L0053:en:NOT. (accessed 26 December 2012).
22. U.S. Department of Health and Human Services. Organ Procurement and Transplantation Network (OPTN) Policies. Policy 12.0. Available at: http://optn.transplant.hrsa.gov/PoliciesandBylaws2/policies/pdfs/ policy-172.pdf. (accessed 26 December 2012).
23. Segev DL, Muzaale AD, Caffo BS, et al,. Perioperative mortality and long-term survival following live kidney donation. JAMA 2010; 303: 959.
24. Ommen ES, LaPointe Rudow D, Medapalli RK, Schroppel B, Murphy B,. When good intentions are not enough: obtaining follow-up data in living kidney donors. Am J Transplant 2011; 11: 2575.
25. Fehrman-Ekholm I, Elinder CG, Stenbeck M, Tyden G, Groth CG,. Kidney donors live longer. Transplantation 1997; 64: 976.
26. Boudville N, Prasad GV, Knoll G, et al,. Meta-analysis: risk for hypertension in living kidney donors. Ann Intern Med 2006; 145: 185.
27. Garg AX, Prasad GV, Thiessen-Philbrook HR, et al,. Cardiovascular disease and hypertension risk in living kidney donors: an analysis of health administrative data in Ontario, Canada. Transplantation 2008; 86: 399.
28. Carter JS, Pugh JA, Monterrosa A,. Non-insulin-dependent diabetes mellitus in minorities in the United States. Ann Intern Med 1996; 125: 221.
29. Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ,. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension 2008; 52: 818.
30. Lentine KL, Segev DL, Axelrod D, et al,. Racial variation in medical outcomes among older living kidney donors (From the WHOLE-DONOR Disparities Collaborative). J Am Soc Nephrol 2012; 23 (Suppl.): 93A.
31. Doshi MD, Goggins MO, Li L, Garg AX,. Medical outcomes in African American live kidney donors: a matched cohort study. Am J Transplant 2013; 13: 111.
32. Delmonico F,. A report of the Amsterdam Forum on the care of the live kidney donor: data and medical guidelines. Transplantation 2005; 79 (Suppl. 6): S53.
33. AST/ASTS/NATCO/UNOS Joint Societies Work Group. Evaluation of the Living Kidney Donor-a Consensus Document from the AST/ASTS/NATCO/UNOS Joint Societies Work Group. Available at http://www.asts.org/Tools/Download.aspx?fid=1427 (accessed 12 September 2012).
34. van 't Riet E, Dekker JM, Sun Q, Nijpels G, Hu FB, van Dam RM,. Role of adiposity and lifestyle in the relationship between family history of diabetes and 20-year incidence of type 2 diabetes in U.S. women. Diabetes Care 2010; 33: 763.
35. Doshi M, Garg AX, Gibney E, Parikh C,. Race and renal function early after live kidney donation: an analysis of the United States Organ Procurement and Transplantation Network Database. Clin Transplant 2010; 24: E153.
36. Nogueira JM, Weir MR, Jacobs S, et al,. A study of renal outcomes in obese living kidney donors. Transplantation 2010; 90: 993.
37. Cherikh WS, Pan-Yen F, Taranto SE,. Prior living kidney donors who were subsequently placed on the waiting list: an updated OPTN Analysis. Am J Transplant 2008; 8 (Suppl 2): 335.
38. Remuzzi G, Schieppati A, Ruggenenti P,. Clinical practice. Nephropathy in patients with type 2 diabetes. N Engl J Med 2002; 346: 1145.
39. Kiberd BA, Clase CM,. Cumulative risk for developing end-stage renal disease in the US population. J Am Soc Nephrol 2002; 13: 1635.
40. Steiner RW,. 'Normal for now' or 'at future risk': a double standard for selecting young and older living kidney donors. Am J Transplant 2010; 10: 737.
41. Reeves-Daniel A, Bailey A, Assimos D, et al,. Donor-recipient relationships in African American vs. Caucasian live kidney donors. Clin Transplant 2011; 25: E487.
42. Lentine KL, Schnitzler MA, Xiao H, et al,. Associations of recipient illness history with hypertension and diabetes after living kidney donation. Transplantation 2011; 91: 1227.
43. Genovese G, Friedman DJ, Ross MD, et al,. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010; 329: 841.
44. Cohen DM, Mittalhenkle A, Scott DL, Young CJ, Norman DJ,. African American living-kidney donors should be screened for APOL1 risk alleles. Transplantation 2011; 92: 722.
45. Kopp JB, Nelson GW, Sampath K, et al,. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 2011; 22: 2129.
46. Friedman DJ, Kozlitina J, Genovese G, Jog P, Pollak MR,. Population-based risk assessment of APOL1 on renal disease. J Am Soc Nephrol 2011; 22: 2098.
47. Kanji Z, Powe CE, Wenger JB, et al,. Genetic variation in APOL1 associates with younger age at hemodialysis initiation. J Am Soc Nephrol 2011; 22: 2091.
48. Madhavan SM, O'Toole JF, Konieczkowski M, Ganesan S, Bruggeman LA, Sedor JR,. APOL1 localization in normal kidney and nondiabetic kidney disease. J Am Soc Nephrol 2011; 22: 2119.
49. Quaggin SE, George AL Jr,. Apolipoprotein l1 and the genetic basis for racial disparity in chronic kidney disease. J Am Soc Nephrol 2011; 22: 1955.
50. Reeves-Daniel AM, Depalma JA, Bleyer AJ, et al,. The APOL1 gene and allograft survival after kidney transplantation. Am J Transplant 2011; 11: 1025.
51. Collins KS, Hall A, Neuhaus C,. U.S. Minority Health: A Chartbook. New York: The Commonwealth Fund, 1999.
52. Kaiser Family Foundation. Key Facts: Race, Ethnicity and Medical Care, Prepared by Cara James, Megan Thomas, and Marsha Lillie-Blanton. Available at: http://www.kff.org/minorityhealth/ 6069-index.cfm (accessed 7 September 2011). 2007.
53. Agency for Healthcare Research and Quality (AHRQ). Health Care Coverage Analyses of the 2006 National Healthcare Quality and Disparities Reports (Coverage Analyses). Available at: https://www.cms.gov/MedicaidCHIPQualPrac/ Downloads/2006disparities-2.pdf (accessed 7 September 2011).
54. Downie DL, Schmid D, Plescia MG, et al,. Racial disparities in blood pressure control and treatment differences in a Medicaid population, North Carolina, 2005-2006. Prev Chronic Dis 2011; 8: A55.
55. Powe NR, Melamed ML,. Racial disparities in the optimal delivery of chronic kidney disease care. Med Clin North Am 2005; 89: 475.
56. Gibney EM, Doshi MD, Hartmann EL, Parikh CR, Garg AX,. Health insurance status of US living kidney donors. Clin J Am Soc Nephrol 2010; 5: 912.
57. United States Renal Data System. 2011 Annual Data Report, Chapter 1:Iincidence, prevalence, patient characteristics, and treatment modalities. Available at: http://www.usrds.org/2011/pdf/v2-ch01-11.pdf (accessed 12 September 2012).
58. Feehally J,. Ethnicity and renal replacement therapy. Blood Purif 2010; 29: 125.
59. Young CJ, Gaston RS,. Renal transplantation in black Americans. N Eng J Med 2000; 343: 1545.
60. Gore JL, Danovitch GM, Litwin MS, Pham PT, Singer JS,. Disparities in the utilization of live donor renal transplantation. Am J Transplant 2009; 9: 1124.
61. Kucirka LM, Grams ME, Lessler J, et al,. Association of race and age with survival among patients undergoing dialysis. JAMA 2011; 306: 620.
62. Reeves-Daniel A, Adams PL, Daniel K, et al,. Impact of race and gender on live kidney donation. Clin Transplant 2009; 23: 39.
63. Udayaraj U, Ben-Shlomo Y, Roderick P, et al,. Social deprivation, ethnicity, and uptake of living kidney donor transplantation in the United Kingdom. Transplantation 2012; 93: 610.